Failed trial

Alzheimer; News from the web:

The companies developing aducanumab, Biogen and its partner Eisai, announced that they halted two late-stage trials of the experimental drug after an independent group’s analysis showed that the trials were unlikely to “meet their primary endpoint.”

The Cambridge, Massachusetts-based biotech giant joins a long list of companies in the last decade that have failed to find a treatment for Alzheimer’s.

Read all about it HERE

Preventing Alzheimer’s

Alzheimer; News from the web:

Yes now we are at the stage that doctors are seriously think they may have found a way to prevent Alzheimer’s to happen. In May, doctors in New York will start testing a novel gene therapy

Read all about it HERE

The end to senior moments near?

Alzheimer; News from the web:

A new drug shows promising results: Early results indicate that the drug could reverse natural, age-related cognitive decline. Researchers also believe that it might help patients whose memories are impaired because of conditions such as depression, schizophrenia and Alzheimer’s disease.

Read all about it HERE